Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 10:51 PM
Ignite Modification Date:
2025-12-24 @ 10:51 PM
NCT ID:
NCT02910869
Eligibility Criteria:
Inclusion Criteria:
* Completion of the MOVE! Program between 2006-2015 with attendance in at least 75% of classes for group A cohort.
* Completion of the MOVE! Program from 2012-2015 with participation in \>75% of activities for group B cohort.
* The patient understands and has signed the study informed consent form.
* Veteran enrolled in the VA Healthcare System and followed by a VA primary care provider.
Exclusion Criteria:
* History of, or current diagnosed DSM-IV-TR eating disorder (i.e., anorexia nervosa or bulimia nervosa) or any current compensatory behaviors (e.g., vomiting, laxative use, excessive exercise).
* Individuals with prescription medication usage, or other medical/psychological conditions that could interfere with the physician's ability to assess the effect of the test results on weight loss.
* History of bipolar disorder, or organic brain syndromes; report hospitalization for any psychiatric disorder within the last 12 months.
* Are currently participating in a weight loss program and/or taking weight loss medication.
* Lost \> 5% of body weight during the past 6 months or history of bariatric surgery.
* Failure to complete screening appointments.
* Health problems which may influence the ability to walk for physical activity or be associated with unintentional weight change, including cancer treatment within the past 5 years or tuberculosis.
Healthy Volunteers:
True
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
75 Years
Study:
NCT02910869
Study Brief:
Protocol Section:
NCT02910869